Two milligrams a week is the maximum, and the earliest it can be reached is week 13.
The steps after 0.5 mg are optional: 0.5 mg, 1 mg and 2 mg are all maintenance doses. This page puts the schedule on your calendar and shows what each dose did in the trials, how side effects change with the dose, and what the label says about a late or missed shot.
What is the Ozempic dosing schedule, with my dates?
Enter the date of your first dose. Pick the maintenance dose your prescriber is aiming for, and the list shows the earliest date the label allows for each step.
Log each shot and the app keeps the dates for you.
Open the appThe numbers along the bottom of the chart are weeks of treatment. These are the earliest dates the label allows, not a plan. The label says a dose may be increased when more blood sugar control is needed, and many people stay on 0.5 mg or 1 mg. Your prescriber decides each step.
| Weeks | Weekly dose mg | What the label says |
|---|---|---|
| 1 to 4 | 0.25 | Starting dose for everyone |
| 5 onward | 0.5 | First maintenance dose |
| 9 onward, if needed | 1 | After at least 4 weeks on 0.5 mg |
| 13 onward, if needed | 2 | After at least 4 weeks on 1 mg; the maximum |
Ozempic prescribing information, section 2.2.1
What do the first twelve weeks look like?
Put together, the label and the level model give this picture of the fastest path to 1 mg.
| Weeks | Dose | Level, as a share of settled 1 mg | What the label notes |
|---|---|---|---|
| 1 to 4 | 0.25 mg | 12% rising to 23% | Starting dose; side effects are most often reported while doses are rising |
| 5 to 8 | 0.5 mg | 36% rising to 48% | First dose with trial results for blood sugar |
| 9 to 12 | 1 mg, if needed | 73% rising to 97% | Allowed after at least 4 weeks on 0.5 mg |
Level: our model, weekly peaks. Notes: Ozempic prescribing information, sections 2.2 and 6.1.1
The first month is mostly preparation. By its end the level is under a quarter of what a settled 1 mg dose gives, and the trials in the label report results for 0.5 mg and above, not for the starting dose.
Why does Ozempic start so low?
To reduce stomach and gut side effects. The label says so directly: the dose escalation is there to reduce the risk of gastrointestinal adverse reactions, and most reports of nausea, vomiting and diarrhea in the trials came during the dose increases.1
The level in the blood also takes time to build. Semaglutide has a half-life of about one week, so each weekly dose lands on top of what is left from the earlier ones, and the label puts steady state at 4 to 5 weeks of weekly dosing.1 That is about the length of each step.
In our model of the fastest schedule, the weekly peak during the four weeks on 0.25 mg runs at 12%, 18%, 22% and 23% of the settled peak on 1 mg. On 0.5 mg it runs at 36%, 43%, 46% and 48%. After the step to 1 mg it takes four more weeks to pass 95%.
What is each dose for?
The label gives each strength a role.1
| Dose | Role in the label |
|---|---|
| 0.25 mg | Starting dose for 4 weeks |
| 0.5 mg | Maintenance dose for blood sugar control |
| 1 mg | Maintenance dose for blood sugar control; the maintenance dose for people with type 2 diabetes and chronic kidney disease |
| 2 mg | Maintenance dose for blood sugar control, and the maximum |
Ozempic has three approved uses, all in adults with type 2 diabetes: to improve blood sugar control alongside diet and exercise, to reduce the risk of major cardiovascular events in people who also have cardiovascular disease, and to reduce the risk of kidney function decline, kidney failure and cardiovascular death in people who also have chronic kidney disease.1 Weight loss is not one of them.
What did each dose do in the trials?
The clearest comparison is a 30-week trial of Ozempic on its own. It assigned 388 adults whose type 2 diabetes was not controlled by diet and exercise to placebo, 0.5 mg or 1 mg.1
HbA1c started at about 8% in all three groups. Average body weight at the start was 89 to 97 kg. This trial did not test 2 mg.
Most of the effect was already there at 0.5 mg. HbA1c fell 1.4 points on 0.5 mg and 1.6 points on 1 mg, and about seven in ten people on either dose finished below 7%. The higher dose added about a kilogram of weight loss: 4.7 kg against 3.8 kg.1
The 2 mg dose was tested against 1 mg in a separate 40-week trial of 961 people already taking metformin, with or without a sulfonylurea. HbA1c fell 2.1 points on 2 mg and 1.9 points on 1 mg, and 64% against 56% finished below 7%. Weight fell 6.4 kg and 5.6 kg, a difference the label describes as not statistically significant.1
2 mg against 1 mg, week 40
The same pattern runs through the other trials in the label, against active drugs and over longer periods.1
| Trial | Weight on 0.5 mg | Weight on 1 mg kg | Comparison group kg |
|---|---|---|---|
| 30 weeks, against placebo | −3.8 kg | −4.7 | −1.2 |
| 56 weeks, against sitagliptin | −4.2 kg | −5.5 | −1.7 |
| 30 weeks, against insulin glargine | −3.2 kg | −4.7 | +0.9 |
| 56 weeks, against exenatide ER | not tested | −4.8 | −2.0 |
Mean change in body weight from the start of each trial.
Do side effects rise with the dose?
Yes, for the stomach and gut. The label's table of common reactions comes from the placebo-controlled trials.1
Placebo 262 people, 0.5 mg 260, 1 mg 261. Most reports of nausea, vomiting and diarrhea came during the dose increases.
One in five people on 1 mg reported nausea, against one in sixteen on placebo. Few of them gave up: 3.1% on 0.5 mg and 3.8% on 1 mg stopped treatment because of stomach and gut reactions, against 0.4% on placebo. In the trial of the top dose, these reactions occurred in 34% of people on 2 mg and 30.8% on 1 mg.1
Does twice the dose mean twice the level?
Yes. The label says exposure rises in proportion to the dose across 0.5 mg, 1 mg and 2 mg. The measured steady-state concentrations show it: about 65 ng/mL on 0.5 mg and 123 ng/mL on 1 mg, and in the trial of the top dose 111.1 ng/mL on 1 mg against 222.1 ng/mL on 2 mg.1
The results did not double with it. Going from 1 mg to 2 mg doubled the level and moved HbA1c by a further 0.2 points.
Which dose was used in the heart and kidney trials?
The lower two. The cardiovascular trial ran for about two years in people with type 2 diabetes at high cardiovascular risk and combined the 0.5 mg and 1 mg doses. A major cardiovascular event, meaning cardiovascular death, a non-fatal heart attack or a non-fatal stroke, occurred in 6.6% of people on Ozempic and 8.9% on placebo.1
The kidney trial used 1 mg in people with type 2 diabetes and chronic kidney disease. Its main outcome, a composite of a sustained fall in kidney function, kidney failure and death from kidney or cardiovascular causes, occurred in 18.7% on Ozempic and 23.2% on placebo.1 The label names 1 mg, the dose in that trial, as the maintenance dose for people with chronic kidney disease.
Outcome trials in the label
Neither trial tested 2 mg. The label ties the step to 2 mg to blood sugar control.
What happens to my other diabetes medicines when the dose goes up?
Two points in the label matter at each step.1
Insulin and sulfonylureas. Taken together with Ozempic they raise the risk of low blood sugar, including severe low blood sugar. The label says the risk may be lowered by reducing the dose of the sulfonylurea or the insulin, which is a decision for the prescriber when Ozempic is started or increased.
Tablets in general. Ozempic slows the emptying of the stomach, which could change how other oral medicines are absorbed. In the clinical pharmacology trials it did not change their absorption to a clinically relevant degree, but the label still asks for caution.
What should be watched while the dose is rising?
The label singles out the start and the increases for three things.1
Fluids and kidneys. Acute kidney injury has been reported with semaglutide, mostly in people who became dehydrated through nausea, vomiting or diarrhea. The label tells prescribers to monitor kidney function in people who report such reactions, especially when Ozempic is started and when the dose is raised.
Eyes. In the two-year trial, complications of diabetic retinopathy occurred in 3.0% of people on Ozempic and 1.8% on placebo, and the gap was larger in those who already had retinopathy: 8.2% against 5.2%. The label notes that a rapid improvement in blood sugar has been linked to a temporary worsening of retinopathy.
Pregnancy plans. Because the drug takes weeks to leave the body, the label says to stop Ozempic at least 2 months before a planned pregnancy.
Does the risk of low blood sugar rise with the dose?
On its own, hardly. With insulin, yes. The label reports low blood sugar separately for Ozempic alone and for Ozempic added to basal insulin, both over 30 weeks.1
| Low blood sugar with symptoms, 70 mg/dL or below | Placebo | 0.5 mg | 1 mg |
|---|---|---|---|
| Ozempic alone | 0% | 1.6% | 3.8% |
| Added to basal insulin | 15.2% | 16.7% | 29.8% |
Ozempic prescribing information, Table 2.1
No one on Ozempic alone had a severe episode, meaning one that needed another person's help. Added to basal insulin, severe episodes occurred in 1.5% of people on 1 mg and in none on 0.5 mg or placebo.1 This is the background to the label's advice that the dose of insulin or a sulfonylurea may need to come down.
What else changes besides the stomach?
The label lists a few measured changes from the placebo-controlled trials.1
On Ozempic 0.5 mg or 1 mg
Heart rate fell by 0.3 beats a minute on placebo, and the enzyme changes were not seen on placebo. Gallstones were reported in 1.5% of people on 0.5 mg and 0.4% on 1 mg, and in no one on placebo. Fatigue, a changed sense of taste and dizziness were each reported in more than 0.4%.1
Do age, kidneys or liver change the dose?
No. The label recommends no dose adjustment for kidney impairment, including kidney failure, and none for liver impairment; in both, the level of the drug did not change to a clinically relevant degree.1
Older adults were well represented in the trials: 23.6% of people on Ozempic in the blood sugar trials were 65 or older, and 48% in the cardiovascular trial. The label found no overall differences in safety or effectiveness between them and younger patients, and adds that greater sensitivity in some older people cannot be ruled out.1
Ozempic is not approved for children: its safety and efficacy have not been established in pediatric patients.1
Do people follow the schedule in practice?
Often not. The best data are for Wegovy, the same drug at higher doses for weight management. A study of 110,748 people in Denmark who filled semaglutide prescriptions for weight found that only 10% followed the recommended increase every four weeks. By their fifth prescription, 13% had reached the top dose, and over the study period a quarter had filled the top dose at least once.3
The Ozempic label leaves room for this. Each step above 0.5 mg is written as "may be increased", and only when more blood sugar control is needed.1 Staying on a dose that works is within the label, and so is waiting longer than four weeks before a step.
Which pen holds which dose?
Ozempic pens hold several weekly doses, and each pen is built for certain doses only.1
| Pen | Delivers | Doses in one pen |
|---|---|---|
| 2 mg / 3 mL | 0.25 mg or 0.5 mg | Four doses of 0.25 mg and two of 0.5 mg, or four doses of 0.5 mg |
| 4 mg / 3 mL | 1 mg | Four doses |
| 8 mg / 3 mL | 2 mg | Four doses |
| Single-dose prefilled syringe | 0.25 mg, 0.5 mg or 1 mg | One |
Ozempic prescribing information, section 3 and highlights.1
The first pen therefore covers the first six weeks: four starting doses and the first two doses of 0.5 mg. A step up to 1 mg or 2 mg means a different pen, not more of the old one.
The single-dose syringe
The current label adds a second form: a prefilled syringe that holds one complete dose of 0.25 mg, 0.5 mg or 1 mg and is used once. The dose is the one printed on the carton and the syringe, and the instructions say to check that label before injecting. The 2 mg dose exists only as a pen.1
The syringe's instructions also say not to warm it with hot water or a microwave, and not to use it if it has been frozen or thawed.1
Storage
Before first use a pen is kept in the refrigerator, at 36°F to 46°F, away from the cooling element, and in its carton. Ozempic that has been frozen must not be used. Between doses the pen is stored with its cap on and without a needle attached, protected from heat and sunlight, and a new needle is used for each injection.1
After its first use a pen can be kept for 56 days, at room temperature up to 86°F (30°C) or in a refrigerator. It must not be frozen.1
What if I miss a dose?
Take it as soon as possible if no more than 5 days have passed. After 5 days, skip it and take the next dose on the usual day. In both cases the weekly schedule then continues as before.1
The curve is a model built on the label's half-life of about one week, for a settled dose. It is not a blood test.
The window is wide because the drug leaves slowly. On the day a dose is due, the level is still at about 62% of the weekly peak in our model. Five days later it is at 38%. The label says semaglutide stays in the circulation for about 5 weeks after the last dose.1
The Ozempic label gives no rule for restarting after several missed doses. The Wegovy label does: after two or more missed doses in a row, it says to restart the dose increases at a lower dose.2 After a long gap on Ozempic, the dose to resume on is a question for the prescriber.
What if too much is injected?
The label's section on overdose is short. It says to treat the symptoms, to consider contacting the Poison Help line at 1-800-222-1222 or a medical toxicologist, and that a prolonged period of observation may be needed because the drug's half-life is about one week.1 The first pen can deliver either 0.25 mg or 0.5 mg, so the selected dose is worth checking before each injection.
Can I change the day or the time?
Yes to both. Ozempic is taken on the same day each week, at any time of day, with or without meals. The day can be changed as long as at least 2 days, more than 48 hours, separate the two doses.1
The injection goes under the skin of the abdomen, the thigh or the upper arm, with a different spot each week when the same body region is used. People who also take insulin inject the two separately and never mix them; the same region is acceptable if the two injections are not next to each other.1
How is this different from the Wegovy schedule?
Ozempic and Wegovy contain the same drug, semaglutide, and both start at 0.25 mg for four weeks. They part ways after that.1,2
| Ozempic | Wegovy injection | |
|---|---|---|
| Approved for | Type 2 diabetes | Weight reduction, cardiovascular risk and MASH |
| Steps | 0.25, 0.5, 1, 2 mg | 0.25, 0.5, 1, 1.7, 2.4 mg |
| Highest dose | 2 mg | 7.2 mg |
| Missed dose | Take within 5 days | Take if the next dose is more than 2 days away |
Current prescribing information for each product.1,2
The 1.7 mg and 2.4 mg doses that appear in some Ozempic charts online are Wegovy doses. Ozempic pens are made for 0.25, 0.5, 1 and 2 mg. The Wegovy dosing schedule has its own calendar.
Weight loss in the Ozempic trials, at lower doses and in people with type 2 diabetes, was 3.8 kg on 0.5 mg and 4.7 kg on 1 mg at 30 weeks, against 1.2 kg on placebo.1
Short answers to common questions
How long do I stay on 0.25 mg of Ozempic?
Four weeks. The label then moves everyone to 0.5 mg once a week.
When can I go up to 1 mg?
After at least 4 weeks on 0.5 mg, which makes week 9 the earliest, and only if more blood sugar control is needed. The prescriber decides.
How long does it take to reach 2 mg?
At least 12 weeks: four on 0.25 mg, four on 0.5 mg and four on 1 mg. The first 2 mg dose is in week 13 at the earliest.
Is 2 mg much stronger than 1 mg?
A little. In the trial that compared them, HbA1c fell 2.1 points on 2 mg and 1.9 on 1 mg, and the difference in weight loss, 6.4 kg against 5.6 kg, was not statistically significant.
Can I stay on 0.5 mg?
Yes. It is a maintenance dose in the label, and the steps to 1 mg and 2 mg are for people who need more blood sugar control.
I missed my Ozempic dose by four days. What now?
Take it as soon as possible: the label's window is 5 days. Then go back to the usual day, keeping at least 2 days between doses.
How many doses are in an Ozempic pen?
Four in the 1 mg and 2 mg pens. The 2 mg / 3 mL starter pen gives four doses of 0.25 mg plus two of 0.5 mg, or four of 0.5 mg.
Can I stay on 0.25 mg?
The label does not list it as a maintenance dose. It is the starting dose for 4 weeks, and the maintenance doses are 0.5 mg, 1 mg and 2 mg. A person who cannot tolerate 0.5 mg should discuss the next step with the prescriber.
Can I take Ozempic together with insulin?
Yes, as separate injections that are never mixed. They may go into the same body region if the two spots are not next to each other. The combination raises the risk of low blood sugar, and the label says a lower insulin dose may reduce that risk.
Do I need a lower dose with kidney disease?
No. The label recommends no dose adjustment for kidney impairment. For people with type 2 diabetes and chronic kidney disease it names 1 mg as the maintenance dose, reached after at least 4 weeks on 0.5 mg.
How the calendar works
The calendar adds 4, 8 and 12 weeks to the date of the first dose. Those are the earliest points at which the label allows 0.5 mg, 1 mg and 2 mg. It does not know your blood sugar results, which is what the label ties each step to.
The bars show the label's published figures for the 30-week trial and for the pool of placebo-controlled trials. The late-dose curve comes from our level model: one compartment, a half-life of 7 days, a peak 2 days after the injection, and a long run of weekly doses before the missed one.
Sources
- OZEMPIC (semaglutide) injection prescribing information, NDA 209637/S-039, revised May 2026. U.S. Food and Drug Administration; sections 1, 2.1, 2.2, 3, 6.1, 12.3, 14 and 16. accessdata.fda.gov
- WEGOVY (semaglutide) prescribing information, NDA 215256/S-025, revised June 2026. U.S. Food and Drug Administration; sections 1, 2.2 and 2.4. accessdata.fda.gov
- Ladebo L, Ernst MT, Mailhac A, Dirksen C, Bojsen-Møller KN, Pottegård A. Real-world use of semaglutide for weight management: patient characteristics and dose titration. A Danish cohort study. Diabetes Care 2024;47:1834-1837. doi:10.2337/dc24-1082
Related analyses
Zepbound dosing schedule: every step from 2.5 to 15 mg, with your dates
Mounjaro dosing schedule: 2.5 mg to 15 mg, week by week, with your own dates
Ozempic side effects: how common each one is by dose, and when they ease
Ozempic vs Mounjaro: what the head-to-head trial and the two labels show
Log each dose and the app shows which week of the schedule you are in.
Open Dose Insider